PT96230A - Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana - Google Patents

Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana

Info

Publication number
PT96230A
PT96230A PT96230A PT9623090A PT96230A PT 96230 A PT96230 A PT 96230A PT 96230 A PT96230 A PT 96230A PT 9623090 A PT9623090 A PT 9623090A PT 96230 A PT96230 A PT 96230A
Authority
PT
Portugal
Prior art keywords
binding
human
antagonists
polipeptideo
interleuquin
Prior art date
Application number
PT96230A
Other languages
English (en)
Other versions
PT96230B (pt
Inventor
Lata Ramanathan
Gail F Seelig
Paul P Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT96230A publication Critical patent/PT96230A/pt
Publication of PT96230B publication Critical patent/PT96230B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT96230A 1989-12-20 1990-12-18 Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana PT96230B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45357089A 1989-12-20 1989-12-20

Publications (2)

Publication Number Publication Date
PT96230A true PT96230A (pt) 1991-10-15
PT96230B PT96230B (pt) 1998-06-30

Family

ID=23801108

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96230A PT96230B (pt) 1989-12-20 1990-12-18 Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana

Country Status (26)

Country Link
US (1) US6358509B1 (pt)
EP (1) EP0506826B1 (pt)
JP (1) JPH0730116B2 (pt)
KR (1) KR960016862B1 (pt)
AT (1) ATE136906T1 (pt)
AU (1) AU639754B2 (pt)
CA (1) CA2071908C (pt)
CZ (1) CZ283050B6 (pt)
DE (1) DE69026627T2 (pt)
DK (1) DK0506826T3 (pt)
ES (1) ES2085983T3 (pt)
FI (1) FI104180B (pt)
GR (1) GR3020325T3 (pt)
HU (1) HU215245B (pt)
IE (1) IE74708B1 (pt)
IL (1) IL96714A0 (pt)
MX (1) MX9203401A (pt)
MY (1) MY106507A (pt)
NO (1) NO922457L (pt)
NZ (1) NZ236511A (pt)
OA (1) OA09704A (pt)
PT (1) PT96230B (pt)
SK (1) SK635290A3 (pt)
TW (1) TW221675B (pt)
WO (1) WO1991009059A1 (pt)
ZA (1) ZA9010190B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714146A (en) * 1992-08-26 1998-02-03 Board Of Regents Of The University Of Washington IL-4 bone therapy
KR100398819B1 (ko) 1993-09-02 2004-02-05 트러스티스 오브 다트마우스 칼리지 gp39길항제를포함하는약제조성물
US20020193575A1 (en) 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
WO1995007301A1 (en) * 1993-09-07 1995-03-16 Smithkline Beecham Corporation Recombinant il4 antibodies useful in treatment of il4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US5705154A (en) * 1995-03-08 1998-01-06 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
JP2001511187A (ja) * 1997-02-28 2001-08-07 エンゾー セラピュウティクス， インコーポレイテッド 選択的免疫ダウンレギュレーション（ｓｉｄｒ）を行う新規プロセス
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US7507706B1 (en) 1998-12-14 2009-03-24 Genetics Institute, Llc Cytokine receptor chain
US6506539B2 (en) * 2000-04-06 2003-01-14 Fuji Photo Film Co., Ltd. Dye complex and optical information recording medium
WO2001092340A2 (en) 2000-05-26 2001-12-06 Immunex Corporation Use of interleukin-4 antagonists and compositions thereof
US20020076409A1 (en) * 2000-07-12 2002-06-20 March Carl J. Method for treating cancer
US20030170258A1 (en) * 2001-05-09 2003-09-11 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (SIDR)
FR2838444B1 (fr) 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
AU2003251633A1 (en) * 2002-07-01 2004-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Il-21 as a regulator of immunoglobin production
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
WO2004096849A2 (en) * 2003-04-25 2004-11-11 University Of Manitoba Peptide-based cytokine/chemokine vaccines against allergy
NZ547588A (en) 2003-11-07 2009-05-31 Immunex Corp Antibodies that bind interleukin-4 receptor
JP4943161B2 (ja) 2003-12-23 2012-05-30 ジェネンテック， インコーポレイテッド 新規抗ｉｌ１３モノクローナル抗体での癌の処置
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
RU2382049C2 (ru) * 2004-08-03 2010-02-20 Новартис Аг ЧЕЛОВЕЧЕСКИЕ МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА К ЧЕЛОВЕЧЕСКОМУ ИНТЕРЛЕЙКИНУ-4 (hIL-4)
PE20060560A1 (es) * 2004-08-03 2006-06-27 Novartis Ag Anticuerpos de interleucina-4 humana
CA2743394C (en) * 2008-11-17 2018-01-02 Koebenhavns Universitet Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
CA2796633C (en) 2010-04-23 2020-10-27 Genentech, Inc. Production of heteromultimeric proteins
US10689447B2 (en) 2011-02-04 2020-06-23 Genentech, Inc. Fc variants and methods for their production
WO2012106587A1 (en) 2011-02-04 2012-08-09 Genentech, Inc. Fc VARIANTS AND METHODS FOR THEIR PRODUCTION
HK1220919A1 (zh) * 2013-04-05 2017-05-19 F. Hoffmann-La Roche Ag 抗il-4抗体和双特异性抗体及其用途
RU2016107435A (ru) 2013-09-13 2017-10-18 Дженентек, Инк. Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
EP3683232A1 (en) 2013-09-13 2020-07-22 F. Hoffmann-La Roche AG Methods and compositions comprising purified recombinant polypeptides
HRP20231139T1 (hr) 2014-05-06 2024-01-05 F. Hoffmann - La Roche Ag Proizvodnja heteromultimernih proteina upotrebom stanica sisavaca
WO2019148405A1 (zh) * 2018-02-01 2019-08-08 北京凯因科技股份有限公司 IL-4Rα抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ZA872781B (en) 1986-05-19 1987-10-05 Immunology Ventures B-cell stimulating factor
AU629536B2 (en) * 1988-02-02 1992-10-08 Schering Biotech Corporation Method of reducing immunoglobulin e responses

Also Published As

Publication number Publication date
EP0506826B1 (en) 1996-04-17
IL96714A0 (en) 1991-09-16
NO922457D0 (no) 1992-06-19
FI104180B1 (fi) 1999-11-30
US6358509B1 (en) 2002-03-19
DE69026627T2 (de) 1996-08-22
ES2085983T3 (es) 1996-06-16
KR920703642A (ko) 1992-12-18
HU9202073D0 (en) 1992-09-28
JPH0730116B2 (ja) 1995-04-05
CZ283050B6 (cs) 1997-12-17
ATE136906T1 (de) 1996-05-15
EP0506826A1 (en) 1992-10-07
AU7176291A (en) 1991-07-18
SK279933B6 (sk) 1999-06-11
FI104180B (fi) 1999-11-30
FI922847A0 (fi) 1992-06-18
CA2071908C (en) 2002-04-30
NO922457L (no) 1992-06-19
FI922847L (fi) 1992-06-18
DK0506826T3 (da) 1996-05-13
TW221675B (pt) 1994-03-11
GR3020325T3 (en) 1996-09-30
ZA9010190B (en) 1991-08-28
KR960016862B1 (ko) 1996-12-23
MY106507A (en) 1995-06-30
OA09704A (en) 1993-08-30
IE74708B1 (en) 1997-07-30
SK635290A3 (en) 1999-06-11
MX9203401A (es) 1992-07-01
NZ236511A (en) 1993-02-25
AU639754B2 (en) 1993-08-05
PT96230B (pt) 1998-06-30
JPH04506359A (ja) 1992-11-05
HUT64568A (en) 1994-01-28
WO1991009059A1 (en) 1991-06-27
DE69026627D1 (de) 1996-05-23
IE904589A1 (en) 1991-07-03
CZ635290A3 (en) 1997-08-13
HU215245B (hu) 1998-11-30
CA2071908A1 (en) 1991-06-21

Similar Documents

Publication Publication Date Title
MX9203401A (es) Anticuerpos antagonistas de la interleukina-4 humana.
ATE249476T1 (de) Cyclin d1 und seine cdna
ATE184019T1 (de) Monoklonale antikörper gegen rezeptor-induzierte bindungsstellen
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ATE40602T1 (de) Immunchemisches messverfahren.
DE3855890D1 (de) Verfahren zur herstellung von imunodiagnose-mitteln
BR9709958A (pt) Polipeptídeos capaz de formar estruturas de ligaçãode antígeno com especificidade para os antígenos de rhesus d o dna que os codifica e o processo para sua preparação e uso
DE69115917D1 (de) Humane gammainterferonantagonisten
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE3867537D1 (de) Mischung von monoklonalen antikoerpern zur bestimmung der creatinkinaseaktivitaet.
AT375367B (de) Verfahren zur herstellung von als histamin h2-rezeptor-antagonisten wirkenden nitroverbindungen
FI883778A7 (fi) Tyyppiä III olevan prokollageenin propeptidin vasta-aine ja määritysenetelmä, jossa sitä käytetään.
DE68921374D1 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
JPS5350323A (en) Production of antiserum and quantitative analysis of protein by said antiserum
DE69430313D1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
TR199901648T2 (xx) Laminin'in nidojen domenine ba�lanan antikorlar�n �retilmesi ve kullan�m�.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE68912100D1 (de) 4,4,5,8-Tetramethyl-1-oxaspiro(2.5)octan, Verfahren zu seiner Herstellung und seine Verwendung als Ausgangsprodukt in der Herstellung von 2,2,3,6-Tetramethyl-cyclohexan-carboxaldehyd.
FI873257A7 (fi) Monoklonaaliset vasta-aineet spesifisiä IgE-pintareseptoreita varten ja näitä vasta-aineita tuottavat hybridisolulinjat ja vasta-aineiden käyttö
DE3787220D1 (de) Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma.
FI830311A7 (fi) määritysmenetelmä fysiologisesti aktiivisten haptenien pitoisuuden määrittämiseksi, jossa hapteeni sitoutuu immunogeenin kantajaan ja kilpailee haptenia vastaan olevien vasta-aineiden sitoutumispaikoista
ATE84318T1 (de) Monoklonale antikoerper, spezifisch von in vivo von fibrinogen abgeleiteten derivatstuecken.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910620

FG3A Patent granted, date of granting

Effective date: 19980313

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990930